| Literature DB >> 27139719 |
Becky J Buelow1, James W Verbsky1,2, John M Routes1,2.
Abstract
INTRODUCTION: Newborn screening (NBS) for Severe combined immunodeficiency (SCID)/severe T cell lymphopenia (sTCL) is being increasingly used worldwide. AREAS COVERED: In this manuscript we will discuss the following: 1) The rationale for screening newborns for SCID/sTCL; 2) The scientific basis for the use of the T cell receptor excision circle (TREC) assay in screening newborns for SCID/sTCL; 3) The published outcomes of current NBS programs. Expert commentary: 4) Some of the ethical dilemmas that occur when screening newborns for SCID. Finally, we will discuss the future directions for expanding NBS to include other primary immunodeficiencies.Entities:
Keywords: Newborn screening (NBS); T cell lymphopenia (TCL); T cell receptor excision circle (TREC); review; severe combined immunodeficiency (SCID)
Mesh:
Substances:
Year: 2016 PMID: 27139719 DOI: 10.1080/17474086.2016.1180243
Source DB: PubMed Journal: Expert Rev Hematol ISSN: 1747-4094 Impact factor: 2.929